Behnood Bikdeli, MD, MS, discusses his long-term follow-up to the HI-PRO study, which noted apixaban’s lasting effects on venous thromboembolism.
Behnood Bikdeli, MD, MS
Advertisement
Behnood Bikdeli, MD, MS, is a physician at Mass General Brigham and assistant professor of medicine at Harvard University.
Articles by Behnood Bikdeli, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
STREAM: Statin Discontinuation Noninferior in Older Adults Without CVD
2
Bepirovirsen Functional Cure Durable Through Week 96 in Chronic Hepatitis B
3
AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke
4
Common Diuretic Linked to Home Blood Pressure Lowering After Stroke
5